Clinical and laboratory-instrumental characteristic of multisystem inflammatory syndrome in children

Authors

DOI:

https://doi.org/10.15574/PP.2022.90.44

Keywords:

multisystem inflammatory syndrome, MIS-C, SARS-CoV-2, children

Abstract

Purpose - to improve diagnostics and making multisystem inflammatory syndrome diagnosis in children based on the study of the clinical course and determination of laboratory and instrumental features.

Materials and methods. 15 cases of multisystem inflammatory syndrome in children who were hospitalized in the Infectious Diseases Boxed Department No.1 of the Vinnytsya Regional Children’s Clinical Hospital in 2021 were analyzed.

Results. The most common symptom was fever. Gastrointestinal disorders (53.33%), neurocognitive and vegetative symptoms (86.67%) were also found in children. Arthralgias, myalgias and pains in the lower extremities were in 33.33% of children, respiratory symptoms - in 20.00% of ones. Almost half of the children had skin rashes at physical examination. Scleritis and conjunctivitis was also noted in the quarter children. Leukocytosis was detected in 8 children (53.33%) in the results of blood count. Majority of children had elevated erythrocyte sedimentation rate, C-reactive protein and fibrinogen. D-dimer was increased in all children. 46.67% of children, according to chest ultrasound had fluid in the pleural cavity up to 7-10 mm, signs of interstitial pulmonary edema, increased echo-signals along the axillary line and the consolidation zone in the middle right lung from 3 mm to 6 mm. 60.0% of children had enlarged liver, spleen, fluid in the abdomen and enlarged multiple mesenteric lymph nodes according abdominal ultrasound.

Conclusions. The diagnosis of multisystem inflammatory syndrome should be made according to the main criteria. It requires differential diagnosis with a number of infectious and systemic diseases. Prolonged fever and neurocognitive symptoms were the most common symptoms in hospitalized patients. Gastrointestinal and cardiovascular disorders, skin rashes prevailed. Typical laboratory changes were elevated markers of inflammation, evidence of coagulopathy and markers of previous coronavirus infection. Significant features among echosonographic changes were enlargement of parenchymal organs and signs of effusion in the cavities. Child protection from the impact of coronavirus infection should be improved.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.

No conflict of interests was declared by the authors.

References

AAP. (2020). Multisystem inflammatory syndrome in children (MIS-C) interim guidance. URL: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance/.

AAP. (2021). Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance. Last Updated 11/15/2021. URL: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance/.

Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP et al. (2021). Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health. 5 (5): 323-331. https://doi.org/10.1016/S2352-4642(21)00050-X

Algarni AS, Alamri NM, Khayat NZ, Alabdali RA, Alsubhi RS, Alghamdi SH. (2022). Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations. World Journal of Pediatrics. 18 (2): 83-90. https://doi.org/10.1007/s12519-021-00499-w; PMid:34982402 PMCid:PMC8725428

Belay ED, Abrams J, Oster ME, Giovanni J, Pierce T, Meng L et al. (2021). Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic. JAMA Pediatr. 175 (8): 837-845. https://doi.org/10.1001/jamapediatrics.2021.0630; PMid:33821923 PMCid:PMC8025123

Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC et al. (2020). Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa478; PMid:32338708 PMCid:PMC7197612

CDC. (2021). Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C). URL: https://www.cdc.gov/mis/misc/hcp/index.html?CDC_AA_refVal=httpswww.cdc.govmishcpindex.html.

CDC. (2022). Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States. URL: https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance.

Dionne A, Son MBF, Randolph AG. (2022). An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. The Pediatric Infectious Disease Journal. 41 (1): e6-e9. https://doi.org/10.1097/INF.0000000000003393; PMid:34889873 PMCid:PMC8658063

Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF et al. (2020). Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 383: 334-346. https://doi.org/10.1056/NEJMoa2021680; PMid:32598831 PMCid:PMC7346765

Godfred-Cato S, Abrams JY, Balachandran N, Jaggi P, Jones K, Rostad CA, Lu AT. (2022). Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome. The Pediatric Infectious Disease Journal. 41 (4): 315-323. https://doi.org/10.1097/INF.0000000000003449; PMid:35093995 PMCid:PMC8919949

Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J et al. (2020). COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States. MMWR Morb Mortal Wkly Rep. 14; 69 (32): 1074-1080. https://doi.org/10.15585/mmwr.mm6932e2; PMid:32790663 PMCid:PMC7440126

Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K et al. (2020). COVID-19 and multisystem inflammatory syndrome in children and adolescents. The Lancet Infectious diseases. 20 (11): 276-E288. https://doi.org/10.1016/S1473-3099(20)30651-4

Mangat C, Bansal P. (2022). Multisystem inflammatory syndrome in children and Kawasaki disease: a clinical conundrum. EMJ Rheumatol. https://doi.org/10.33590/emjrheumatol/22-00025

Sánchez-Oro R, Bandpey MLF, Martínez EG, Prades MÁE, Muñoz EMA. (2021). Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19. Radiologia. 63 (4): 334-344. https://doi.org/10.1016/j.rx.2021.03.001

Son MBF, Friedman K. (2022). COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and outcome. URL: https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-management-and-outcome.

Son MBF, Friedman K. (2022). COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis. URL: https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis?topicRef=129614&source=see_link.

Tuikkala H. (2021). Multysystemnyi zapalnyi syndrom u ditei (MIS-C), poviazanyi z infektsiieiu COVID-19. EBM Guidelines. URL: https://www.dec.gov.ua/wp-content/uploads/2022/01/multysystemnyj-zapalnyj-syndrom-u-ditej-mis-c-covid-19.pdf.

Wesselsa PA, Binglerb MA. (2022). A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children. Progress in Pediatric Cardiology: 65. https://doi.org/10.1016/j.ppedcard.2022.101516; PMid:35313700 PMCid:PMC8925196

Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al. (2020). Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 324 (3): 259-269. https://doi.org/10.1001/jama.2020.10369; PMid:32511692 PMCid:PMC7281356

WHO. (2020). Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. URL: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.

Yousaf AR, Cortese MM, Taylor AW, Broder KR, Oster ME, Wong JM et al. (2022). Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine. August, 2021: a surveillance investigation. The Lancet. https://doi.org/10.1016/S2352-4642(22)00028-1

Published

2022-06-30